Sebastian Obrzut

TitleClinical Professor
InstitutionUniversity of California San Diego
Address200 W. Arbor Drive #8758
San Diego CA 92103
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Georgetown UniversityDoctor of Medicine School of Medicine
    Rensselaer Polytechnic InstituteBS, Biomedical Engineering

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nguyen BJ, Burt A, Baldassare RL, Smitaman E, Morshedi M, Kao S, Chang EY, Obrzut S. The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis. Nucl Med Commun. 2018 Jul; 39(7):699-706. PMID: 29893752.
      View in: PubMed
    2. Obrzut S, McCammack K, Badran KW, Balistreri A, Ou E, Nguyen BJ, Hoh CK, Rose SC. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors. Clin Imaging. 2017 Mar - Apr; 42:43-49. PMID: 27875761.
      View in: PubMed
    3. Chen L, Tiongson JE, Obrzut S, McDaniel MB, Chang HY, Patel J, Friedman PJ, Feld GK, Birgersdotter-Green UM. Standard chest radiograph predicts left ventricular lead location in chronic resynchronization therapy patients more accurately than intraoperative fluoroscopy. J Interv Card Electrophysiol. 2012 Dec; 35(3):323-30. PMID: 22843127.
      View in: PubMed
    4. Obrzut S, Bykowski J, Badran K, Hayeri MR, Hoh CK. Utility of fluorodeoxyglucose-positron emission tomography in the identification of new lesions in lung cancer patients for the assessment of therapy response. Nucl Med Commun. 2010 Dec; 31(12):1008-15. PMID: 20926977.
      View in: PubMed
    5. Obrzut S, Tiongson J, Jamshidi N, Phan HM, Hoh C, Birgersdotter-Green U. Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy. J Cardiovasc Transl Res. 2010 Dec; 3(6):643-51. PMID: 20842468; PMCID: PMC2993897.
    6. Obrzut S, Jamshidi N, Karimi A, Birgersdotter-Green U, Hoh C. Imaging and modeling of myocardial metabolism. J Cardiovasc Transl Res. 2010 Aug; 3(4):384-96. PMID: 20559785; PMCID: PMC2899022.
    7. Lee JK, Obrzut SL, Yi ES, Deftos LJ, Bouvet M. Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism. Endocr Pract. 2007 Jul-Aug; 13(4):380-3. PMID: 17669714.
      View in: PubMed
    8. Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med Commun. 2007 Jan; 28(1):7-13. PMID: 17159543.
      View in: PubMed
    9. Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol. 2005 Nov; 32(8):869-74. PMID: 16253812.
      View in: PubMed
    10. Ghodsian M, Obrzut SL, Hyde CC, Watts WJ, Schiepers C. Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT. Clin Nucl Med. 2005 Nov; 30(11):717-20. PMID: 16237292.
      View in: PubMed
    11. Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol. 2004 Nov-Dec; 6(6):411-6. PMID: 15564152.
      View in: PubMed
    12. Obrzut SL, Halpern BS, Monchamp T, Grabski K, Watts WJ, Czernin J. The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor. Mol Imaging Biol. 2004 May-Jun; 6(3):126-30. PMID: 15193246.
      View in: PubMed